Houston / Pittsburgh / Vancouver / Waterloo / St. Louis / Geneva / Aberdeen / West Hollywood / Rochester / Seattle / Oslo / Charlottesville / Minneapolis / Sheffield / Boston / Baltimore / Bruxelles / New York / Cambridge / London / /
Company
Amgen / Proc Natl Acad Sci U S A / Novartis Pharmaceuticals / Hershey / InforMEDical Communications Inc. / Margulies AG / 20InforMEDical Communications Inc. / Chugai Pharmaceuticals / /
University of Rochester School / University of Waterloo / Penn State University College of Medicine / Anderson Cancer Center / Institute of Medical Sciences / S. Hershey Medical Center / University School / University of Virginia / Norwegian Radium Hospital / Oncology Centre / University of Minnesota Cancer Center / University of Aberdeen / Cornell University Medical College / University Drive / Weston Park Hospital / Milton S. Hershey Medical Center / Laboratory Medicine / University of Arkansas / Johns Hopkins University / University of Washington School / /
IndustryTerm
Prevention of Bone Metastases In breast cancer / treatment for prostate cancer / pharmaceutical agents / energy / tumor site / therapy for breast cancer / treatment for pain related to metastatic bony disease / treatment of neuropathic cancer / treatment of breast cancer / treatment of skeletal breast and prostate bone cancer / metastatic site / treatment for metastatic bone cancer / treatment of operable breast cancer / therapy for prostate cancer / therapy for patients with primary breast cancer / treatment of osteoporosis / prevention of metastatic bone cancer / treatment of metastatic breast cancer / /
MedicalCondition
cumulative disease / Smad tumor / multiple myeloma / primary breast cancer / advanced lung cancer / metastasic breast cancer / skeletal metastases / metastatic bone disease / tumor-directed osteoclast-mediated osteolysis / bone resorption / Prostate cancer / breast cancer / osteolysis / osteolytic bone metastases / Nahlieli O. Severe osteomyelitis / cancer metastasis / tumor / osteoblastic metastases / Smith MR. Osteoporosis / nerve injury / advanced cancers / Cancer / tumors / breast cancer bone metastases / inflammatory states / bone metastases / Breast cancer tumors / testosterone deficiency / osteoporosis / refractory prostate cancer / prostate bone cancer metastases / metastases / extraosseous disease / multigenic program mediating breast cancer metastasis / breast and prostate cancer / primary tumor / osteonecrosis / hypercalcemia / pathologic fracture / carcinoma / Metastatic Bone Cancer / Advances inTreating Metastatic Bone Cancer / myeloma and other solid tumors / metastatic breast cancer / estrogen deficiency / breast metastases / skeletal diseases / Breast cancer bone metastasis / MS / early-stage diseases / Bone Metastases In breast cancer / Osteopenia / cancers / osteoblastic bone metastases / different tumor / chronic condition / metastatic bone cancers / Disease / neuropathic cancer / osteolytic metastases / advanced carcinoma / bone cancer / bone disease / pain / metastatic cancer / so prevalent / metastatic bone cancer / operable breast cancer / prostate cancer bone metastasis / metastatic bony disease / estrogen and subsequent osteopenia / increased osteoclastic bone resorption / screening for osteoporosis / /
16Massachusetts General Hospital Cancer Center / World Health Organization / Division of Hematology/Oncology / University of Aberdeen / Milton S. Hershey Medical Center / Norwegian Radium Hospital / 1Milton S. Hershey Medical Center / University of Virginia / University of Minnesota Cancer Center / Department of Medicine / Department of Orthopedic Surgery / Universite¤ Libre de Bruxelles / Washington University School of Medicine / Cancer Research Centre / Sidney Kimmel Comprehensive Cancer Center / Academic Unit of Clinical Oncology / American Association for Cancer Research / Harvard Medical School / University of Texas M.D. Anderson Cancer Center / University of Rochester School of Medicine and Dentistry / University of Washington School of Medicine / Penn State University College of Medicine / Johns Hopkins University / University of Arkansas / University of Waterloo / 13Parkside Oncology Centre / Institute for Myeloma and Bone Cancer Research / Department of Oncology / Institute of Medical Sciences / Weston Park Hospital / Department of Pathology and Laboratory Medicine / Cornell University Medical College / /
Person
Matthew R. Smith / Michael J. Rogers / Katherine N.Weilbaecher / Jules Bordet / Robert L.Vessella / Larry J. Suva / G. David Roodman / / /
Advances inTreating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference Allan Lipton,1 James R. Berenson,2 Jean-Jacques Body,3 Brendan F. Boyce,4 Oyvind S. Bruland,5 Michael A. Carducci,6 Charles